Gecina upgraded to Buy from Neutral at Goldman Sachs

Goldman Sachs analyst Jonathan Kownator upgraded Gecina to Buy from Neutral with a price target of EUR 112, down from EUR 114.60. The recent underperformance of the shares, which creates an attractive opportunity post the company’s strong fiscal 2023 results and a “necessary adjustment to valuation, which is now behind the company,” the analyst tells investors in a research note.